An Adjuvanted Zoster Vaccine Elicits Potent Cellular Immune Responses in Mice without QS21

Investigators evaluated the immunogenicity of a newly formulated gE protein-based herpes zoster vaccine containing Second-generation Lipid Adjuvant, a synthetic TLR4 ligand, formulated in an oil-in-water emulsion without QS21/